Friday Five – 5 Notable Healthcare Acquisitions of 2022
According to experts mergers and acquisitions returned to typical levels this past year. This week’s Friday Five highlights the healthcare acquisitions of 2022 we found most notable.
June: Oracle buys Cerner ($28.3B)
On December 20, 2021, Oracle Corporation (@oracle) and Cerner Corporation (@Cerner) jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. Cerner is a provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities. The deal closed on June 8, 2022.
At the time Health IT Answers reached out to our pool of experts to get their take on the acquisition. Take a look back to see what they had to say.
July: Amazon and One Medical ($3.9B)
Amazon (@amazonnews) and One Medical (@onemedical) announced that they have entered into a definitive merger agreement under which Amazon will acquire One Medical. One Medical is a human-centered, technology-powered national primary care organization on a mission to make quality care more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services that are convenient to where people work, shop, and live.
October: Optum, part of UnitedHealth Group Acquires Change Healthcare ($13B)
UnitedHealth Group’s Optum (@Optum) unit completed its $13 billion acquisition of the software and data analytics firm Change Healthcare after successfully fending off a U.S. Justice Department challenge of the deal, according to Forbes.
October: Walgreens Boots Alliance Accelerates Full Acquisition of CareCentrix ($392M)
Walgreens Boots Alliance, Inc. (@WalgreensNews) announced the acceleration of its plans to acquire full ownership of CareCentrix (@carecentrix), expanding its reach into the growing homecare sector and advancing its healthcare long-term growth strategy. WBA entered into a definitive agreement to acquire the remaining 45% stake for approximately $392 million, which is based on the exit multiple agreed to at the time of WBA’s initial majority investment announcement in CareCentrix.